308 related articles for article (PubMed ID: 26802722)
1. Systemic sclerosis: An update in 2016.
Desbois AC; Cacoub P
Autoimmun Rev; 2016 May; 15(5):417-26. PubMed ID: 26802722
[TBL] [Abstract][Full Text] [Related]
2. Systemic sclerosis: Update for oral health care providers.
Alhendi FJ; Werth VP; Sollecito TP; Stoopler ET
Spec Care Dentist; 2020 Sep; 40(5):418-430. PubMed ID: 33448431
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the diagnosis and treatment of systemic sclerosis.
Kowal-Bielecka O; Bielecki M; Kowal K
Pol Arch Med Wewn; 2013; 123(1-2):51-8. PubMed ID: 23344666
[TBL] [Abstract][Full Text] [Related]
4. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
Diot E; Valat C; Boissinot E; Giraudeau B; Asquier E; Guilmot JL; Lemarié E; Diot P
Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
[TBL] [Abstract][Full Text] [Related]
5. Very early diagnosis of systemic sclerosis.
Bellando-Randone S; Guiducci S; Matucci-Cerinic M
Pol Arch Med Wewn; 2012; 122 Suppl 1():18-23. PubMed ID: 23222375
[TBL] [Abstract][Full Text] [Related]
6. [Lung impairment in systemic sclerosis].
Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
[TBL] [Abstract][Full Text] [Related]
7. The contemporary management of systemic sclerosis.
Eldoma M; Pope J
Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
[TBL] [Abstract][Full Text] [Related]
8. [An update on systemic sclerosis].
Kowal-Bielecka O
Ann Acad Med Stetin; 2010; 56 Suppl 1():80-2. PubMed ID: 21365948
[TBL] [Abstract][Full Text] [Related]
9. An update on biomarker discovery and use in systemic sclerosis.
Matsushita T; Takehara K
Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.
Tan A; Denton CP; Mikhailidis DP; Seifalian AM
Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S66-74. PubMed ID: 21586221
[TBL] [Abstract][Full Text] [Related]
11. Systemic sclerosis.
Denton CP; Khanna D
Lancet; 2017 Oct; 390(10103):1685-1699. PubMed ID: 28413064
[TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis/scleroderma: a treatable multisystem disease.
Hinchcliff M; Varga J
Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
[TBL] [Abstract][Full Text] [Related]
13. [Nuclear auto-antibodies: a useful tool for the diagnosis, the classification and the prognosis of systemic sclerosis].
Hachulla E; Dubucquoi S
Rev Med Interne; 2004 Jun; 25(6):442-7. PubMed ID: 15158315
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.
Becker MO; Riemekasten G
Expert Rev Clin Immunol; 2016; 12(2):115-35. PubMed ID: 26558747
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and management approaches for scleroderma lung disease.
Schoenfeld SR; Castelino FV
Ther Adv Respir Dis; 2017 Aug; 11(8):327-340. PubMed ID: 28621173
[TBL] [Abstract][Full Text] [Related]
16. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
17. Cardiac complications of systemic sclerosis: recent progress in diagnosis.
Boueiz A; Mathai SC; Hummers LK; Hassoun PM
Curr Opin Rheumatol; 2010 Nov; 22(6):696-703. PubMed ID: 20657283
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease in systemic sclerosis: current and future treatment.
Giacomelli R; Liakouli V; Berardicurti O; Ruscitti P; Di Benedetto P; Carubbi F; Guggino G; Di Bartolomeo S; Ciccia F; Triolo G; Cipriani P
Rheumatol Int; 2017 Jun; 37(6):853-863. PubMed ID: 28063071
[TBL] [Abstract][Full Text] [Related]
19. Targeting vascular disease in systemic sclerosis.
Kowal-Bielecka O
Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):401-7. PubMed ID: 17214586
[TBL] [Abstract][Full Text] [Related]
20. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
